Collaborating With Patients to Make Treatment Decisions Based on Benefits and Risks of Medications Associated With Tardive Dyskinesia

REGISTER


Forgot your login? GET HELP

​​​​​​

Many patients who are at risk for tardive dyskinesia fear that they might develop the involuntary neurological movement disorder, yet it is possible for clinicians to convey a realistic assessment of the benefits and risks of medications that might induce TD. Clinicians need to be aware of the importance of communicating reasonable risk in a way that will not alarm patients, using tools such as probabilities and phronesis in discussions with their patients.

See the entire activity.​​​​​​​​

J Clin Psychiatry. 2020;81(6):NU19047BR2C.

https://doi.org/10.4088/JCP.NU19047BR2C